A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency
NCT00911937
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
963
Enrollment
INDUSTRY
Sponsor class
Conditions
Overactive Bladder
Interventions
DRUG:
Fesoterodine
DRUG:
Placebo
Sponsor
Pfizer